Examlex
Zeracizumab is an experimental angiogenesis inhibitor targeting vascular endothelial growth factor that is being tested for the treatment of advanced, chemotherapy-naive, non-squamous non-small cell lung cancer (NSCLC) . Part of the drug company's evaluation process is to analyze the 1-year survival after treatment to determine the clinical efficacy of the experimental treatment. The results are given in the table below. Which of the following best represents the number needed to harm for the zeracizumab-containing regimen?
Indirect Approach
A communication strategy where the main point or request is not presented immediately but is preceded by context, background, or supportive arguments.
Providing Sample
Offering a portion or example of a product or work to demonstrate quality, style, or function.
Reader's Attention
The focus and engagement of a reader with the content, influenced by factors such as interest, readability, and presentation.
Persuasive Claim
An assertion made in an attempt to convince others of its validity, often used in arguments or advertisements.
Q19: A 2-year-old boy who attends daycare is
Q43: A 55-year-old man is scheduled to have
Q43: A 5-year-old boy is brought to the
Q44: A surveillance study is conducted to assess
Q71: A 3-year-old boy is being evaluated for
Q71: A 26-year-old woman, gravida 1 para 0,
Q103: A 62-year-old man comes to the emergency
Q192: A 40-year-old woman with major depression comes
Q227: An 18-year-old man comes to the office
Q297: A 58-year-old asymptomatic woman comes to the